Cargando…

Bone mineral density in patients diagnosed with giant cell arteritis taking glucocorticoids: a case–control study

OBJECTIVE: The standard treatment for GCA is high-dose glucocorticoids (GCs). It is unknown whether GCs are more detrimental to BMD at the spine or the hip. The aim of this study was to investigate the effect of GCs on BMD at the lumbar spine and hip in patients with GCA being treated with GCs. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geressu, Adam, Sultan, Zain, Bukhari, Marwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Concise Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950852/ https://www.ncbi.nlm.nih.gov/pubmed/36844917 http://dx.doi.org/10.1093/rap/rkad020

Ejemplares similares

Stratified glucocorticoid monotherapy is safe and effective for most cases of giant cell arteritis
por: Karabayas, Maira, et al.
Publicado: (2020)

Paradoxically protective effect of glucocorticoids on bone mass and fragility fracture in a large cohort: a cross-sectional study
por: Bukhari, Marwan, et al.
Publicado: (2021)

Evaluation of adjunctive mycophenolate for large vessel giant cell arteritis
por: Karabayas, Maira, et al.
Publicado: (2020)

The relationship between glycated haemoglobin levels and the risk of giant cell arteritis – a case–control study
por: Mukhtyar, Chetan, et al.
Publicado: (2020)

Increased number of cases of giant cell arteritis and higher rates of ophthalmic involvement during the era of COVID-19
por: Luther, Rosamond, et al.
Publicado: (2020)

Giant Cell Arteritis: A Systematic Review and Meta‐Analysis of Test Accuracy and Benefits and Harms of Common Treatments
Publicado: (2023)

Glucocorticoids Are Not Associated with Bone Mineral Density in Patients with Polymyalgia Rheumatica, Giant Cell Arteritis and Other Vasculitides—Cross-Sectional Baseline Analysis of the Prospective Rh-GIOP Cohort
por: Palmowski, Andriko, et al.
Publicado: (2022)

Assessment of Low Bone Mineral Density in Untreated Patients with Takayasu's Arteritis
por: Mo, Lingfei, et al.
Publicado: (2021)

Predictors of fragility fracture and low bone mineral density in patients with a history of parental fracture
por: Dey, Mrinalini, et al.
Publicado: (2019)

The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis
por: Jakobsson, Karin, et al.
Publicado: (2016)

Impact of Glucocorticoid Cumulative Doses in a Real-Life Cohort of Patients Affected by Giant Cell Arteritis
por: Castan, Paul, et al.
Publicado: (2022)

Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis
por: Emamifar, Amir, et al.
Publicado: (2021)

Successful use of ixekizumab for glucocorticoid-free remission maintenance in giant cell arteritis
por: Tomelleri, Alessandro, et al.
Publicado: (2022)

Cell therapy in Huntington's disease: Taking stock of past studies to move the field forward
por: Bachoud‐Lévi, Anne‐Catherine, et al.
Publicado: (2020)

Effects of Denosumab on Bone Metabolic Markers and Bone Mineral Density in Patients Treated with Glucocorticoids
por: Sawamura, Masato, et al.
Publicado: (2017)

Genetic Predispositions of Glucocorticoid Resistance and Therapeutic Outcomes in Polymyalgia Rheumatica and Giant Cell Arteritis
por: Smutny, Tomas, et al.
Publicado: (2019)

Healthcare Costs of Potential Glucocorticoid-Associated Adverse Events in Patients with Giant Cell Arteritis
por: Best, Jennie H, et al.
Publicado: (2019)

Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids Tapering
por: Venerito, Vincenzo, et al.
Publicado: (2022)

Possible role of lymphocytes in glucocorticoid-induced increase in trabecular bone mineral density
por: Grahnemo, Louise, et al.
Publicado: (2015)

Taking off the gown: Impact of discontinuing contact precautions for extended-spectrum β-lactamase (ESBL)–producing organisms
por: Gottlieb, Lindsey B., et al.
Publicado: (2021)

Clinical Features and Differential Diagnoses in Laryngeal Mucoepidermoid Carcinoma
por: Mokhtari, Sepideh, et al.
Publicado: (2011)

We’ll take it from here: Veterans Affairs OPAT management of home IV therapy initiated at community hospitals
por: Tiemann, Allison R., et al.
Publicado: (2023)

Glucocorticoid-Induced Bone Loss Is Associated with Abnormal Intravertebral Areal Bone Mineral Density Distribution
por: Manning, Louise I., et al.
Publicado: (2013)

Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia
por: Chandler, H., et al.
Publicado: (2019)

Glucocorticoids affect bone mineral density and bone remodelling in OVX sheep: A pilot study
por: Cabrera, Diana, et al.
Publicado: (2018)

Wood's Lamp as an Inexpensive, Handy Tool to Diagnose Solar Urticaria
por: Choudhary, Sanjiv, et al.
Publicado: (2020)

Giant Cell Arteritis: An Atypical Presentation Diagnosed with the Use of MRI Imaging
por: Shambhu, Siddesh, et al.
Publicado: (2016)

Giant cell arteritis with severe intracranial involvement diagnosed and treated early
por: Mineji, Kentaro, et al.
Publicado: (2023)

Glucocorticoid Effects on Tissue Residing Immune Cells in Giant Cell Arteritis: Importance of GM-CSF
por: Wagner, Annette D., et al.
Publicado: (2021)

Reduction in skin cancer diagnoses in the UK during the COVID‐19 pandemic
por: Andrew, T. W., et al.
Publicado: (2021)

Giant Cell Arteritis
por: Coulier, Bruno, et al.
Publicado: (2018)

S219. RISK FACTORS FOR LOW BONE MINERAL DENSITY IN PATIENTS TAKING ANTIPSYCHOTICS
por: Jhon, Min, et al.
Publicado: (2018)

A Case of Alkaptonuria Diagnosed in the 6(th) Decade – A Clinico-Dermoscopic-Histopathological View
por: Ashwini, P. Kombettu, et al.
Publicado: (2021)

Giant Cell Arteritis versus Takayasu Arteritis: An Update
por: Stamatis, Pavlos
Publicado: (2020)

A qualitative study of patient perspectives related to glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis
por: Hoon, Elizabeth, et al.
Publicado: (2019)

Rapid glucocorticoid tapering regimen in patients with giant cell arteritis: a single centre cohort study
por: Mensch, Noemi, et al.
Publicado: (2023)

A case of giant cell arteritis simultaneously diagnosed with chronic subdural hematoma
por: Otani, Yuichiro, et al.
Publicado: (2019)

Mapping the architecture of the temporal artery with photoacoustic imaging for diagnosing giant cell arteritis
por: Naumovska, Magdalena, et al.
Publicado: (2022)

Antimicrobial prescribing practices at a tertiary-care center in patients diagnosed with COVID-19 across the continuum of care
por: Stevens, Ryan W., et al.
Publicado: (2020)

Primary care challenges in diagnosing and referring patients with suspected rheumatoid arthritis: a national cross-sectional GP survey
por: Scott, Ian C, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tsbr3rhfoo0u7b1rue0u8rje86